Advanced Hematologic Malignancies
7 clinical trials · Condition
◉ Watch Advanced Hematologic Malignancies
| Record | Firm | Date |
|---|---|---|
| The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer (NCT04991129) | Suzhou Junjing BioSciences Co., Ltd. | 2021-09-10 |
| Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft (NCT05088356) | Stanford University | 2021-09-07 |
| Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS) (NCT01344707) | 4SC AG | 2011-03-01 |
| Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies (NCT00943592) | University of Chicago | 2006-03-01 |
Track Advanced Hematologic Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.